Literature DB >> 8145063

Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine.

D Yoshida1, Y Ikeda, S Nakazawa.   

Abstract

Trace element such as Cu and Zn have important chemical and biological properties. Recently, tissue Cu and Zn concentrations have been correlated with prognosis in selected malignancies. In addition, depletion of trace metals has suppressive effects on tumor growth in experimental rat models. We measured tissue levels of Cu and Zn and investigated the inhibitory effects on tumor growth in a rat brain tumor model by the Cu-depletion. 9L gliosarcoma cells were injected subcutaneously in 24 anesthetized 5 week old male Fischer-344 rats. Control animals (n = 12) were given a normal diet throughout the experiment and hypocupremic rats (n = 12) were given a Cu-deficient diet beginning 3 weeks before and after tumor implantation, and administered 2 mg of D-Penicillamine peri os., once daily, 3 days before and after implantation. At the time of sacrifice, samples were taken to measure tumor weights. To determine tissue Cu and Zn levels, atomic absorption spectrophotometry was used. Cu, Zn and Cu/Zn ratio were significantly higher in control tumors than brain tissues. Cu levels and Cu/Zn ratio were significantly lower in hypocupremic tumors than those in control tumors. Zn levels in hypocupremic tumors were significantly higher than control tumors. Our study indicated that Cu depletion by a Cu-deficient and D-Penicillamine reduced Cu concentration and Cu/Zn ratio in a tumor model with reduction of tumor weight. A metabolic approach that restricts Cu to alter the microenvironment within the cell must become a new horizon of cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8145063     DOI: 10.1007/bf01050211

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  45 in total

1.  Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate.

Authors:  J O Ogunlewe; D N Osegbe
Journal:  Cancer       Date:  1989-04-01       Impact factor: 6.860

2.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors:  T Matsubara; R Saura; K Hirohata; M Ziff
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

3.  Kinetics of the Zn 2+ - stimulation of human peripheral lmphocytes in vitro.

Authors:  H Rühl; H Kirchner; G Bochert
Journal:  Proc Soc Exp Biol Med       Date:  1971-07

4.  Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis.

Authors:  J T Rutka; C A Myatt; J R Giblin; R L Davis; M L Rosenblum
Journal:  Can J Neurol Sci       Date:  1987-02       Impact factor: 2.104

5.  Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model.

Authors:  D Zagzag; M Goldenberg; S Brem
Journal:  AJR Am J Roentgenol       Date:  1989-07       Impact factor: 3.959

6.  [Trace elements in the serum and cancerous tissue in patients with trophoblastic carcinoma].

Authors:  Y L Fu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  1989-09

7.  Effect of chronic dietary zinc deficiency on cadmium toxicity and carcinogenesis in the male Wistar [Hsd: (WI)BR] rat.

Authors:  M P Waalkes; R Kovatch; S Rehm
Journal:  Toxicol Appl Pharmacol       Date:  1991-05       Impact factor: 4.219

8.  Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.

Authors:  R Siegemund; J Lössner; K Günther; H J Kühn; H Bachmann
Journal:  Acta Neurol Scand       Date:  1991-06       Impact factor: 3.209

9.  Zinc requirement for DNA replication in stimulated human lymphocytes.

Authors:  R O Williams; L A Loeb
Journal:  J Cell Biol       Date:  1973-09       Impact factor: 10.539

10.  Use of the serum copper/zinc ratio in the differential diagnosis of ovarian malignancy.

Authors:  A Lightman; J M Brandes; N Binur; A Drugan; O Zinder
Journal:  Clin Chem       Date:  1986-01       Impact factor: 8.327

View more
  3 in total

1.  Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B.

Authors:  K Watanabe; D Yoshida; M Noha; A Teramoto
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

2.  In vitro and in vivo anti-proliferative evaluation of bis(4'-(4-tolyl)-2,2':6',2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.

Authors:  Dharmasivam Mahendiran; Raju Senthil Kumar; Vijayan Viswanathan; Devadasan Velmurugan; Aziz Kalilur Rahiman
Journal:  J Biol Inorg Chem       Date:  2017-09-07       Impact factor: 3.358

3.  Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy.

Authors:  Kavita Gaur; Alexandra M Vázquez-Salgado; Geraldo Duran-Camacho; Irivette Dominguez-Martinez; Josué A Benjamín-Rivera; Lauren Fernández-Vega; Lesly Carmona Sarabia; Angelys Cruz García; Felipe Pérez-Deliz; José A Méndez Román; Melissa Vega-Cartagena; Sergio A Loza-Rosas; Xaymara Rodriguez Acevedo; Arthur D Tinoco
Journal:  Inorganics (Basel)       Date:  2018-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.